证券代码：002226 证券简称：江南化工 公告编号:2025-031 具体内容详见 2025 年 4 月 29 日公司登载于《证券时报》《中国证券报》《证 券日报》《上海证券报》和巨潮资讯网的《安徽江南化工股份有限公司 2025 年 第一季度报告》（公告编号：2025-032）。 特此公告。 安徽江南化工股份有限公司 安徽江南化工股份有限公司监事会 关于第七届监事会第三次会议决议的公告 本公司及监事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 安徽江南化工股份有限公司(以下简称"公司"或 "本公司")第七届监事会第 三次会议于 2025 年 4 月 23 日以电子邮件等方式通知了各位监事，并于 2025 年 4 月 28 日在公司会议室采用通讯方式召开。会议应出席监事 3 名，实际出席监 事 3 名，公司高级管理人员列席了会议，会议召开程序符合《公司法》和《公司 章程》等有关规定。会议由监事会主席佟彦军先生主持，审议通过了如下议案： 一、审议通过了《安徽江南化工股份有限公司 2025 年第一季度报告》。 经审核，监事会认为：董事会编制和审核公司 2025 年第一季度报告的程 ...

安徽江南化工股份有限公司（以下简称"公司"或"本公司"）第七届董事 会第三次会议于2025年4月23日以电子邮件等方式通知了各位董事，并于2025年4 月28日在本公司会议室采用通讯方式召开。本次会议由董事长杨世泽先生主持， 会议应出席董事9名，实际出席董事9名。会议召开程序符合《公司法》和《公司 章程》等有关规定。会议审议通过了如下议案： （一）审议通过了《安徽江南化工股份有限公司 2025 年第一季度报告》； 证券代码：002226 证券简称：江南化工 公告编号:2025-030 安徽江南化工股份有限公司 关于第七届董事会第三次会议决议的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 公司审计与风险管理委员会审议通过了该议案。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 具体内容详见 2025 年 4 月 29 日登载于《证券时报》《中国证券报》《证券 日报》《上海证券报》和巨潮资讯网的《安徽江南化工股份有限公司 2025 年第 一季度报告》（公告编号：2025-032）。 （二）审议通过了《安徽江南化工股份有限公司 2024 年 ESG 报告》 ...

Group 1: Metal Sector - Zijin Mining's copper production is expected to increase by 6% to 1.07 million tons in 2024 and by 7% to 1.15 million tons in 2025, with gold production rising by 7% to 73 tons in 2024 and by 16% to 85 tons in 2025[14] - The company's net profit forecast for 2025 is 42.06 billion CNY, with a PE ratio of 11.17[11] - The overall metal sector is benefiting from a strong price increase expectation due to supply constraints and demand from the new energy sector[14] Group 2: Building Materials Sector - Keda Manufacturing's total revenue is projected to grow from 57 billion CNY in 2017 to 126 billion CNY in 2024, with overseas revenue increasing from 20 billion CNY to 80 billion CNY, raising its overseas revenue share from 36% to 64%[19] - The net profit forecast for Keda Manufacturing in 2025 is 1.45 billion CNY, with a net profit margin of 6.8%[21] - Sankeshu's revenue is expected to compound at 26% from 2014 to 2024, with a projected net profit growth despite a downturn in the real estate market[36] Group 3: Logistics Sector - SF Holding's operating cash flow is expected to grow by 21% to 32.2 billion CNY in 2024, with a capital expenditure decrease of 27% to 9.9 billion CNY[44] - The company plans to increase its dividend payout ratio to 40% in 2024, enhancing shareholder returns significantly[44] Group 4: Chemical Sector - Yara International is focusing on overseas potassium mining, with a current production capacity of 1 million tons and a target annual output of 180-200 thousand tons[46] - The company is expanding its production capacity with plans for additional million-ton facilities in the future[48]

Investment Rating - The report maintains an "Outperform" rating for the basic chemical industry [2]. Core Viewpoints - The commercialization of humanoid robots is accelerating, with a focus on four major investment themes related to the chemical sector. In Q1 2025, over 35 companies launched new humanoid robot products, with more than 21 from China. The market for humanoid robots is expected to reach 8.239 billion yuan, accounting for about 50% of the global market by 2025 [5][28]. Summary by Sections Market Performance - The basic chemical industry index increased by 2.7% from April 18 to April 25, outperforming the Shanghai Composite Index by 2.1 percentage points and the ChiNext Index by 1.0 percentage points. Year-to-date, the basic chemical industry index has risen by 1.7%, surpassing the Shanghai Composite Index by 3.4 percentage points and the ChiNext Index by 10.8 percentage points [3][16]. Investment Themes 1. **Equity Investment Strategy**: The humanoid robot industry is projected to produce over 10,000 units by 2025, with significant market potential. Chemical companies can enhance their technological attributes through early-stage equity investments [5][28]. 2. **Polymer Materials**: Humanoid robots require various polymer materials, with modified plastics being a key solution for lightweight components. The demand for PEEK is expected to grow significantly, with a projected CAGR of 16.8% from 2022 to 2027 [5][29]. 3. **Tendon Materials**: Tendon systems are crucial for humanoid robots, with UHMWPE and carbon fiber being ideal materials due to their superior properties. Companies like Tongyi Zhong and Nanshan Zhishang are leading in UHMWPE production [5][6]. 4. **Electronic Skin Materials**: The electronic skin market is expected to grow from 6.3 billion USD in 2024 to 30 billion USD by 2034, with companies like Fulei New Materials and Hanwei Technology actively developing flexible sensor materials [5][6]. Product Price Changes - The report lists significant price changes for chemical products, with the top gainers including glyphosate (+16.3%) and liquid nitrogen (+13.7%). Conversely, coal tar saw a decline of 11.8% [5]. Investment Recommendations - Core assets in the chemical sector are entering a long-term value zone, with companies like Baofeng Energy and Wanhua Chemical recommended for investment. Additionally, sectors facing supply constraints, such as vitamins and refrigerants, are highlighted for their potential price elasticity [5][14][15].

Investment Rating - The report maintains an "Outperform" rating for the basic chemical industry [2]. Core Viewpoints - The commercialization of humanoid robots is accelerating, with a focus on four major investment themes related to the chemical sector. In Q1 2025, over 35 companies launched new humanoid robot products, with more than 21 from China. The market for humanoid robots is expected to reach 8.239 billion yuan, accounting for about 50% of the global market by 2025 [5][28]. Summary by Sections Market Performance - The basic chemical industry index increased by 2.7% from April 18 to April 25, outperforming the Shanghai Composite Index by 2.1 percentage points and the ChiNext Index by 1.0 percentage points. Year-to-date, the basic chemical industry index has risen by 1.7%, surpassing the Shanghai Composite Index by 3.4 percentage points and the ChiNext Index by 10.8 percentage points [3][16]. Investment Themes 1. **Equity Investment Strategy**: The humanoid robot industry is projected to produce over 10,000 units by 2025, with significant market potential. Chemical companies can enhance their technological attributes through early-stage equity investments [5][28]. 2. **Polymer Materials**: Humanoid robots require various polymer materials, with modified plastics being a key solution for lightweight components. The demand for PEEK is expected to grow significantly, with a projected CAGR of 16.8% from 2022 to 2027 [5][29]. 3. **Tendon Materials**: Tendon systems are crucial for humanoid robots, with UHMWPE and carbon fiber being ideal materials due to their superior properties. Companies like Tongyi Zhong and Nanshan Zhishang are leading in UHMWPE production [6][29]. 4. **Electronic Skin Materials**: The electronic skin market is expected to grow from 6.3 billion USD in 2024 to 30 billion USD by 2034, with companies like Fulei New Materials and Hanwei Technology actively developing flexible sensor materials [5][29]. Product Price Changes - The report lists significant price changes for chemical products, with the top gainers including glyphosate (+16.3%) and liquid nitrogen (+13.7%). Conversely, coal tar saw a decline of 11.8% [5][6]. Investment Recommendations - Core assets in the chemical sector are entering a long-term value zone, with companies like Baofeng Energy and Wanhua Chemical recommended for investment. Additionally, sectors facing supply constraints, such as vitamins and refrigerants, are highlighted for their potential price elasticity [5][14].

安徽江南化工股份有限公司（以下简称"公司"或"江南化工"）持股5% 以上股东紫金矿业紫南（厦门）投资合伙企业（有限合伙）（以下简称"紫南投 资"）计划自本公告披露之日起15个交易日后的3个月内(窗口期内不减持)以集 中竞价交易及大宗交易方式减持其持有的公司股份不超过79,467,000股（占江南 化工总股本比例不超过3.00%）。 证券代码：002226 证券简称：江南化工 公告编号:2025-029 安徽江南化工股份有限公司 关于持股 5%以上股东减持股份的预披露公告 本次计划减持的股东紫金矿业紫南（厦门）投资合伙企业（有限合伙）保证向 本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 公司于近日收到持股5%以上股东紫金矿业紫南（厦门）投资合伙企业（有 限合伙）出具的《股份减持计划告知函》，现将具体情况公告如下： 一、股东基本情况 1、股东名称：紫金矿业紫南（厦门）投资合伙企业（有限合伙） 2、股东持股情况：截至本公告披露日，紫南投资持有公司股票317,710,341 股，占公司总股本的11.99%，全部 ...

Investment Rating - The report maintains an "Outperform" rating for Jiangnan Chemical [4][7]. Core Views - The consolidation in the explosives industry is ongoing, leading to increased concentration, with strong demand observed in western regions. Projected EPS for 2025-2027 is RMB 0.39, 0.44, and 0.5 respectively, with a 2025 PE valuation set at 20x and a target price of RMB 7.80 [4][7]. Financial Performance Summary - For 2024, the company is expected to achieve a revenue of RMB 9.48 billion, a year-on-year increase of 6.59%, and a net profit attributable to shareholders of RMB 0.89 billion, up 15.26%. The recurring net profit is projected at RMB 0.8 billion, reflecting a growth of 1.12% [4][7]. - The gross profit margin (GPM) is expected to improve to 30.08%, an increase of 0.6 percentage points, while the net profit margin (NPM) is projected to reach 11.94%, up 0.7 percentage points [4][7]. - The company’s revenue from blasting engineering is projected to be RMB 5.1 billion, up 8.2%, while civil explosives revenue is expected to be RMB 2.74 billion, up 6.6%. However, revenue from new energy power is anticipated to decline by 11.3% to RMB 0.78 billion [4][7]. Market Dynamics - The report highlights rapid growth in blasting engineering and overseas markets, with international revenue expected to reach RMB 1.02 billion, a year-on-year increase of 27.9%. Key drivers include significant client development and successful project acquisitions [4][7]. - The company is focusing on restructuring and integrating blasting services, seizing M&A opportunities, and enhancing its integrated mining services to promote sales through blasting [4][7].

Financial Performance - In 2024, the company achieved a revenue of CNY 9.481 billion, representing a year-on-year growth of 6.59% [2] - Total profit reached CNY 1.408 billion, an increase of 14.42% compared to the previous year [2] - Net profit attributable to shareholders was CNY 889 million, up by 15.26% year-on-year [2] - Net assets attributable to shareholders amounted to CNY 9.462 billion, reflecting an 8.57% increase [2] Business Development Strategies - The company is focusing on significant customer development and has successfully secured major engineering projects, outperforming the previous year [2] - Internal collaboration has improved, enhancing synergy between explosive production and blasting companies [2] - The company is steadily growing its international operations [2] Mergers and Acquisitions - The company is actively responding to the "14th Five-Year" plan for the civil explosives industry, which emphasizes supply-side reforms and industry consolidation [2] - Future mergers and acquisitions will focus on internal restructuring and high-quality external acquisitions to broaden profit growth points [2] - The company aims to complete the integration of military explosive assets by the end of 2025 to avoid competition with its controlling shareholder [3] Regional Market Expansion - In Xinjiang, the company has a production capacity of 207,500 tons of industrial explosives, primarily focusing on mixed production [3] - The company plans to optimize its capacity layout based on regional supply-demand relationships and market prices [3] - The company is also targeting the Tibetan market, leveraging the "Belt and Road" initiative to tap into its growth potential [5] Shareholder Engagement - The actual controller, China Weapon Industry Group, remains optimistic about the future of China's economy and capital markets [6] - There are currently no announced plans for shareholding increases by major shareholders, but the company will disclose any future plans as required [6] Engineering Services Development - The company plans to enhance its engineering services segment by focusing on market demand and integrated blasting services [7] - It aims to strengthen strategic partnerships with large mining enterprises and actively pursue blasting service projects [8] - Internationally, the company will implement a "go global" strategy, particularly in resource-rich countries along the "Belt and Road" [8]

Investment Rating - The report assigns a "Buy" investment rating for Jiangnan Chemical [6] Core Views - Jiangnan Chemical achieved a total operating revenue of 9.481 billion yuan in 2024, representing a year-on-year increase of 6.59%, and a net profit attributable to shareholders of 891 million yuan, up 15.26% year-on-year [1] - The increase in profit is primarily attributed to the decline in raw material prices, particularly ammonium nitrate, which saw an average price decrease of 17.40% year-on-year [2] - The company is focusing on enhancing its core competitiveness through increased R&D investment, with the R&D expense ratio rising due to ongoing efforts in technological innovation [3] - The performance of the civil explosives industry is stable, with significant engineering projects exceeding expectations and ongoing market development efforts in various regions [4] Summary by Sections Financial Performance - In Q4 2024, the company reported a single-quarter operating revenue of 2.782 billion yuan, a year-on-year increase of 14.91% and a quarter-on-quarter increase of 23.68% [1] - The revenue composition by product shows: civil explosive products +6.61%, blasting engineering services +8.25%, new energy power generation -11.32%, other civil explosive businesses +17.69%, raw material production and sales +62.73%, and other businesses +5.06% [2] R&D and Innovation - The company has increased its R&D investment, leading to a rise in the R&D expense ratio, which is aimed at enhancing its technological innovation capabilities and core competitiveness [3] Market Development - Jiangnan Chemical has successfully optimized its production capacity structure and exceeded expectations in acquiring major engineering projects, with ongoing efforts to develop markets in regions such as Inner Mongolia, Sichuan, and Xinjiang [4] Profit Forecast - The forecast for net profit attributable to shareholders for 2025-2027 is 1.081 billion, 1.417 billion, and 1.807 billion yuan respectively, with corresponding P/E ratios of 14.3, 10.9, and 8.6 [11]

Investment Rating - The report assigns a "Buy" rating for Jiangnan Chemical, indicating an expected relative increase of over 15% compared to the CSI 300 index in the next six months [6][12]. Core Insights - Jiangnan Chemical, a leading company in the civil explosives industry, achieved a revenue of 9.481 billion yuan in 2024, representing a year-on-year growth of 6.59%. The net profit attributable to shareholders was 891 million yuan, up 15.26% year-on-year [4][8]. - The company's main business in civil explosives showed steady growth, with the revenue from blasting engineering services reaching 5.104 billion yuan, a growth of 8.25% year-on-year, contributing significantly to overall performance [4]. - The company is actively expanding its production capacity and integrating operations, having acquired stakes in Chaoyang Hongshan Chemical and Shaanxi Hongqi Civil Explosives Group, increasing its industrial explosive capacity to 765,500 tons [5]. Summary by Sections Financial Performance - In 2024, Jiangnan Chemical reported a total revenue of 9.481 billion yuan and a net profit of 891 million yuan, with Q4 revenue reaching 2.782 billion yuan, marking a 14.91% increase year-on-year [4][8]. - The company forecasts revenue growth rates of 10.41%, 10.43%, and 10.44% for 2025, 2026, and 2027, respectively, with net profit growth rates of 13.23%, 12.76%, and 10.72% for the same years [8]. Business Expansion and Strategy - Jiangnan Chemical is focusing on integrated services and overseas business expansion, achieving 1.023 billion yuan in overseas revenue, a 27.85% increase year-on-year [4]. - The company is involved in the "Belt and Road" initiative, with successful projects in various countries, enhancing its international market presence [4][5]. Capacity and Market Position - The company is positioned as a consolidation platform for the civil explosives industry, with commitments from its controlling shareholders to resolve industry competition issues by the end of 2025 [5]. - Jiangnan Chemical's production capacity is expected to further increase with the anticipated integration of subsidiaries specializing in overseas operations and electronic detonators [5].